BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24585570)

  • 1. Trial sequence meta-analysis can reject false-positive result calculated from conventional meta-analysis.
    Chen RP; Chen C; Yu JY; Huang XL; Zhou MT; Huang ZM
    Hepatology; 2014 Oct; 60(4):1442-3. PubMed ID: 24585570
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 22095893.
    Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
    Hepatology; 2014 Oct; 60(4):1443-5. PubMed ID: 24585539
    [No Abstract]   [Full Text] [Related]  

  • 3. Is albumin infusion necessary after large volume paracentesis?
    Cárdenas A; Ginès P; Runyon BA
    Liver Int; 2009 May; 29(5):636-40; discussion 640-1. PubMed ID: 19413666
    [No Abstract]   [Full Text] [Related]  

  • 4. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
    Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
    Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At bat with paracentesis: home runs or singles?
    Simon D
    Am J Gastroenterol; 1991 Jan; 86(1):110. PubMed ID: 1986537
    [No Abstract]   [Full Text] [Related]  

  • 7. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
    Widjaja FF; Khairan P; Kamelia T; Hasan I
    Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].
    Manzocchi S; Nendaz M; Spahr L
    Rev Med Suisse; 2012 Oct; 8(358):1956, 1958-60. PubMed ID: 23198648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
    Bernardi M; Caraceni P; Navickis RJ
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
    [No Abstract]   [Full Text] [Related]  

  • 10. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
    Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
    Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tense ascites in cirrhosis: paracentesis with albumin infusion versus spontaneous ascites filtration.
    Robson SC
    HPB Surg; 1994; 7(4):336-40. PubMed ID: 8204557
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention.
    Siddique SM; Porges S; Lane-Fall M; Mehta SJ; Schweickert W; Kinniry J; Taylor A; Lewis JD; Iqbal S; Goldberg D; Shea JA; Stetson R; Coniglio M; Hoteit M; Fishman N; Khungar V
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2630-2633.e2. PubMed ID: 31518719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rational diuretic therapy in patients with liver cirrhosis].
    Vogt B; Reichen J
    Ther Umsch; 2000 Jun; 57(6):355-60. PubMed ID: 10894019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paracentesis in the treatment of ascites in cirrhotic patients].
    Uriz Otano J; Sort P; Arroyo V
    Gastroenterol Hepatol; 1999; 22(7):356-63. PubMed ID: 10535210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.